Affiliations
AffiliationsItem in Clipboard
Economics of Multicomponent Interventions to Increase Breast, Cervical, and Colorectal Cancer Screening: A Community Guide Systematic ReviewGiridhar Mohan et al. Am J Prev Med. 2019 Oct.
. 2019 Oct;57(4):557-567. doi: 10.1016/j.amepre.2019.03.006. Epub 2019 Aug 30. AffiliationsItem in Clipboard
AbstractContext: The Community Preventive Services Task Force recently recommended multicomponent interventions to increase breast, cervical, and colorectal cancer screening based on strong evidence of effectiveness. This systematic review examines the economic evidence to guide decisions on the implementation of these interventions.
Evidence acquisition: A systematic literature search for economic evidence was performed from January 2004 to January 2018. All monetary values were reported in 2016 US dollars, and the analysis was completed in 2018.
Evidence synthesis: Fifty-three studies were included in the body of evidence from a literature search yield of 8,568 total articles. For multicomponent interventions to increase breast cancer screening, the median intervention cost per participant was $26.69 (interquartile interval [IQI]=$3.25, $113.72), and the median incremental cost per additional woman screened was $147.64 (IQI=$32.92, $924.98). For cervical cancer screening, the median costs per participant and per additional woman screened were $159.80 (IQI=$117.62, $214.73) and $159.49 (IQI=$64.74, $331.46), respectively. Two studies reported incremental cost per quality-adjusted life year gained of $748 and $33,433. For colorectal cancer screening, the median costs per participant and per additional person screened were $36.63 (IQI=$7.70, $139.23) and $582.44 (IQI=$91.10, $1,452.12), respectively. Two studies indicated a decline in incremental cost per quality-adjusted life year gained of $1,651 and $3,817.
Conclusions: Multicomponent interventions to increase cervical and colorectal cancer screening were cost effective based on a very conservative threshold. Additionally, multicomponent interventions for colorectal cancer screening demonstrated net cost savings. Cost effectiveness for multicomponent interventions to increase breast cancer screening could not be determined owing to the lack of studies reporting incremental cost per quality-adjusted life year gained. Future studies estimating this outcome could assist implementers with decision making.
Published by Elsevier Inc.
FiguresFigure 1.
Analytic framework. a Interventions addressing…
Figure 1.
Analytic framework. a Interventions addressing multiple structural barriers are considered multicomponent. b Reduced…
Figure 1.Analytic framework. a Interventions addressing multiple structural barriers are considered multicomponent. b Reduced incidence may not apply to all cancers.
Figure 2.
Economic literature search results.
Figure 2.
Economic literature search results.
Figure 2.Economic literature search results.
Similar articlesMohan G, Chattopadhyay S. Mohan G, et al. JAMA Oncol. 2020 Sep 1;6(9):1434-1444. doi: 10.1001/jamaoncol.2020.1460. JAMA Oncol. 2020. PMID: 32556187 Free PMC article.
Attipoe-Dorcoo S, Chattopadhyay SK, Verughese J, Ekwueme DU, Sabatino SA, Peng Y; Community Preventive Services Task Force. Attipoe-Dorcoo S, et al. Am J Prev Med. 2021 Apr;60(4):e189-e197. doi: 10.1016/j.amepre.2020.08.011. Epub 2020 Dec 11. Am J Prev Med. 2021. PMID: 33309455 Review.
Shi JF, Mao AY, Bai YN, Liu GX, Liu CC, Wang H, Cao MM, Feng H, Wang L, Bai FZ, Huang HY, Bai HJ, Zhu J, Yan XX, Zhang J, Ren JS, Li N, Dai M, Chen WQ. Shi JF, et al. Zhonghua Yu Fang Yi Xue Za Zhi. 2020 Mar 6;54(3):306-313. doi: 10.3760/cma.j.issn.0253-9624.2020.03.012. Zhonghua Yu Fang Yi Xue Za Zhi. 2020. PMID: 32187937 Chinese.
Ladabaum U. Ladabaum U. Gastrointest Endosc Clin N Am. 2020 Jul;30(3):479-497. doi: 10.1016/j.giec.2020.02.005. Epub 2020 Apr 9. Gastrointest Endosc Clin N Am. 2020. PMID: 32439083 Review.
Vives N, Travier N, Farre A, Binefa G, Vidal C, Pérez Lacasta MJ, Ibáñez-Sanz G, Niño de Guzmán EP, Panera JA, Garcia M; M-TICS Research Group. Vives N, et al. JMIR Public Health Surveill. 2024 Jul 31;10:e57959. doi: 10.2196/57959. JMIR Public Health Surveill. 2024. PMID: 39083331 Free PMC article. Clinical Trial.
Washington A, Smith L, Anderson G, Randall J, Kayser K, LaJoie S. Washington A, et al. J Cancer Educ. 2024 Apr;39(2):126-138. doi: 10.1007/s13187-023-02385-7. Epub 2023 Nov 24. J Cancer Educ. 2024. PMID: 37996632 Free PMC article. Review.
Subramanian S, Kobrin S, Hoover S, Tan S, Brenner AT, Campbell JE, Hatcher J, Huang B, Jones M, Kenzie ES, Lam H, Liebovitz D, Mishra SI, O'Leary MC, Ortwine KN, Pankratz VS, Paskett ED, Pennell M, Petrik AF, Roesch S. Subramanian S, et al. BMC Health Serv Res. 2024 Nov 6;24(1):1356. doi: 10.1186/s12913-024-11542-7. BMC Health Serv Res. 2024. PMID: 39506739 Free PMC article.
Phillips V, Franco Montoya D, Adams EK. Phillips V, et al. Cancers (Basel). 2024 Mar 13;16(6):1134. doi: 10.3390/cancers16061134. Cancers (Basel). 2024. PMID: 38539469 Free PMC article. Review.
Mohan G, Chattopadhyay S. Mohan G, et al. JAMA Oncol. 2020 Sep 1;6(9):1434-1444. doi: 10.1001/jamaoncol.2020.1460. JAMA Oncol. 2020. PMID: 32556187 Free PMC article.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3